Yousif Capital Management, LLC Emergent Bio Solutions Inc. Transaction History

Yousif Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$7.35 - $13.21 $10,069 - $18,097	-1,370 Reduced 6.4%	20,031 $147,000
Q1 2023 May 02, 2023	SELL	$7.79 - $16.29 $42,136 - $88,112	-5,409 Reduced 20.18%	21,401 $221,000
Q4 2022 Jan 09, 2023	SELL	$11.0 - $21.45 $83,930 - $163,663	-7,630 Reduced 22.15%	26,810 $0
Q3 2022 Nov 04, 2022	SELL	$20.09 - $35.8 $12,214 - $21,766	-608 Reduced 1.73%	34,440 $723,000
Q2 2022 Aug 01, 2022	SELL	$27.42 - $43.63 $171,786 - $273,341	-6,265 Reduced 15.16%	35,048 $1.09 Million
Q1 2022 May 12, 2022	SELL	$36.48 - $52.22 $47,971 - $68,669	-1,315 Reduced 3.08%	41,313 $1.7 Million
Q4 2021 Jan 31, 2022	BUY	$33.11 - $55.01 $1.41 Million - $2.34 Million	42,628 New	42,628 $1.85 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.